A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Incyte Corporation
Merck Sharp & Dohme LLC
Instituto do Cancer do Estado de São Paulo
Sotio Biotech Inc.
Translational Research in Oncology
Xencor, Inc.
Abramson Cancer Center at Penn Medicine
INSYS Therapeutics Inc
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)